Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein

References

• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• HamadaHIshiharaKMasuokaNMikuniKNakajimaNEnhancement of water-solubility and bioactivity of paclitaxel using modified cyclodextrinsJ Biosci Bioeng2006102436937117116587
   PubMed Web of Science ®Google Scholar
• MathewAEMejillanoMRNathJPHimesRHStellaVJSynthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor-activityJ Med Chem19923511451511346275
   PubMed Web of Science ®Google Scholar
• RowinskyEKClinical pharmacology of taxolJ Natl Cancer Inst Monogr1993152537
   PubMedGoogle Scholar
• HajekRVorlicekJSlavikMPaclitaxel (Taxol): a review of its antitumor activity in clinical studies minireviewNeoplasma1996431411548841500
   PubMed Web of Science ®Google Scholar
• RowinskyEKEisenhauerEAChaudhryVArbuckSGDonehowerRCClinical toxicities encountered with paclitaxel (Taxol)Semin Oncol1993204 Suppl 3115
   PubMed Web of Science ®Google Scholar
• CoppJAFangRHLukBTClearance of pathological antibodies using biomimetic nanoparticlesProc Natl Acad Sci U S A201411137134811348625197051
   PubMed Web of Science ®Google Scholar
• HuCMFangRHLukBTZhangLNanoparticle-detained toxins for safe and effective vaccinationNat Nanotechnol201381293393824292514
   PubMed Web of Science ®Google Scholar
• HuCMFangRHCoppJLukBTZhangLA biomimetic nano-sponge that absorbs pore-forming toxinsNat Nanotechnol20138533634023584215
   PubMed Web of Science ®Google Scholar
• ParodiAQuattrocchiNvan de VenALSynthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functionsNat Nanotechnol201381616823241654
   PubMed Web of Science ®Google Scholar
• FangRHHuCMLukBTCancer cell membrane-coated nanoparticles for anticancer vaccination and drug deliveryNano Lett20141442181218824673373
   PubMed Web of Science ®Google Scholar
• HuCMZhangLAryalSCheungCFangRHZhangLErythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platformProc Natl Acad Sci U S A201110827109801098521690347
   PubMed Web of Science ®Google Scholar
• LukBTHuC-MJFangRHInterfacial interactions between natural RBC membranes and synthetic polymeric nanoparticlesNanoscale2014652730273724463706
   PubMed Web of Science ®Google Scholar
• HuCMFangRHLukBT‘Marker-of-self’ functionalization of nanoscale particles through a top-down cellular membrane coating approachNanoscale2013572664266823462967
   PubMed Web of Science ®Google Scholar
• GaoWHuCMFangRHLukBTSuJZhangLSurface functionalization of gold nanoparticles with red blood cell membranesAdv Mater201325263549355323712782
   PubMed Web of Science ®Google Scholar
• PiaoJGWangLGaoFYouYZXiongYYangLErythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapyACS Nano2014810104141042525286086
   PubMed Web of Science ®Google Scholar
• LiLLXuJHQiGBZhaoXYuFWangHCore-shell supramolecular gelatin nanoparticles for adaptive and “on-demand” antibiotic deliveryACS Nano2014854975498324716550
   PubMed Web of Science ®Google Scholar
• KnopKHoogenboomRFischerDSchubertUSPoly(ethylene glycol) in drug delivery: pros and cons as well as potential alternativesAngew Chem Int Ed Engl201049366288630820648499
   PubMed Web of Science ®Google Scholar
• IshidaTMaedaRIchiharaMIrimuraKKiwadaHAccelerated clearance of PEGylated liposomes in rats after repeated injectionsJ Control Release2003881354212586501
   PubMed Web of Science ®Google Scholar
• IshidaTIchiharaMWangXInjection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomesJ Control Release20061121152516515818
   PubMed Web of Science ®Google Scholar
• ArmstrongJKHempelGKolingSAntibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patientsCancer2007110110311117516438
   PubMed Web of Science ®Google Scholar
• DavisMEChenZGShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
   PubMed Web of Science ®Google Scholar
• PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNano-carriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
   PubMed Web of Science ®Google Scholar
• WagnerVDullaartABockAKZweckAThe emerging nanomedicine landscapeNat Biotechnol200624101211121717033654
   PubMed Web of Science ®Google Scholar
• MuzykantovVRDrug delivery by red blood cells: vascular carriers designed by mother natureExpert Opin Drug Deliv20107440342720192900
   PubMed Web of Science ®Google Scholar
• MurcianoJCMedinillaSEslinDAtochinaECinesDBMuzykantovVRProphylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytesNature Biotech2003218891896
   PubMed Web of Science ®Google Scholar
• WangQChengHPengHZhouHLiPYLangerRNon-genetic engineering of cells for drug delivery and cell-based therapyAdv Drug Deliv Rev20159112514025543006
   PubMed Web of Science ®Google Scholar
• FangRHHuCMChenKNLipid insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticlesNanoscale20135198884888823907698
   PubMed Web of Science ®Google Scholar
• ShaHZouZXinKTumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drugpenetration into 3D multicellular spheroids and facilitates effective gastric cancer therapyJ Control Release201520018820025553823
   PubMed Web of Science ®Google Scholar
• ShaHLiRBianXA tumor-penetrating recombinant protein anti-EGFR-iRGD enhance efficacy of paclitaxel in 3D multicellular spheroids and gastric cancer in vivoEur J Pharm Sci201577607225998561
   PubMed Web of Science ®Google Scholar
• ZhaoBXZhaoYHuangYThe efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxelBiomaterials20123382508252022197569
   PubMed Web of Science ®Google Scholar
• ShiGMukthavaramRKesariSSimbergDDistearoyl anchor-painted erythrocytes with prolonged ligand retention and circulation properties in vivoAdv Healthc Mater20143114214823798381
   PubMed Web of Science ®Google Scholar
• DanhierFLecouturierNVromanBPaclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluationJ Control Release20091331111718950666
   PubMed Web of Science ®Google Scholar
• LiangLLinSWDaiWNovel cathepsin B-sensitive paclitaxel conjugate: higher water solubility, better efficacy and lower toxicityJ Control Release2012160361862922410114
   PubMed Web of Science ®Google Scholar
• SugaharaKNScodellerPBraunGBA tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosisJ Control Release2015212596926071630
   PubMed Web of Science ®Google Scholar
• ElzoghbyAOSamyWMElgindyNAAlbumin-based nanoparticles as potential controlled release drug delivery systemsJ Control Release2012157216818221839127
   PubMed Web of Science ®Google Scholar
• DingDTangXCaoXNovel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacyAAPS PharmSciTech201415121322224287627
   PubMed Web of Science ®Google Scholar
• LuJChuanXZhangHFree paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxelsystems in vitro and in vivoInt J Pharm20144711–252553524858391
   PubMedGoogle Scholar
• ZhouJZhaoWYMaXThe anticancer efficacy of paclitaxel liposomes modified with mitochondrialtargeting conjugate in resistant lung cancerBiomaterials201334143626363823422592
   PubMed Web of Science ®Google Scholar
• ShinHCAlaniAWRaoDARockichNCKwonGSMulti-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugsJ Control Release2009140329430019409432
   PubMed Web of Science ®Google Scholar
• GaucherGDufresneMHSantVPKangNMaysingerDLerouxJCBlock copolymer micelles: preparation, characterization and application in drug deliveryJ Control Release20051091–316918816289422
   PubMed Web of Science ®Google Scholar
• ZhuZLiYLiXPaclitaxel-loaded poly(N-vinylpyrrolidone)- b-poly(e-caprolactone) nanoparticles: preparation and antitumor activity in vivoJ Control Release2010142343844619896997
   PubMed Web of Science ®Google Scholar
• HuQGaoXGuGGlioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxelBiomaterials201334225640565023639530
   PubMed Web of Science ®Google Scholar
• DanhierFVromanBLecouturierNTargeting of tumor endothe-lium by RGD-grafted PLGA-nanoparticles loaded with paclitaxelJ Control Release2009140216617319699245
   PubMed Web of Science ®Google Scholar
• BaleASBaroneSJrScottCSCooperGSA review of potential neurotoxic mechanisms among three chlorinated organic solventsToxicol Appl Pharmacol2011255111312621609728
   PubMed Web of Science ®Google Scholar
• XuPWangRWangXOuyangJRecent advancements in erythrocytes, platelets, and albumin as delivery systemsOnco Targets Ther201692873288427274282
   PubMed Web of Science ®Google Scholar
• SunYSuJLiuGAdvances of blood cell-based drug delivery systemsEur J Pharm Sci20179611512827496050
   PubMed Web of Science ®Google Scholar
• TzounakasVLKaradimasDGPapassideriISSeghatchianJAntonelouMHErythrocyte-based drug delivery in transfusion medicine: wandering questions seeking answersTransfus Apher Sci201756462663428774826
   PubMed Web of Science ®Google Scholar
• HarisaGIBadranMMAlanaziFKErythrocyte nanovesicles: biogenesis, biological roles and therapeutic approach: erythrocyte nanovesiclesSaudi Pharm J201725181728223857
   PubMed Web of Science ®Google Scholar
• TanSWuTZhangDZhangZCell or cell membrane-based drug delivery systemsTheranostics20155886388126000058
   PubMed Web of Science ®Google Scholar
• ZhouHFanZLemonsPKChengHA facile approach to func-tionalize cell membrane-coated nanoparticlesTheranostics2016671012102227217834
   PubMed Web of Science ®Google Scholar